Moderate associations between the use of levonorgestrel-releasing intrauterine device and metabolomics profile.

The use of LNG-IUD was associated with several moderate metabolic changes, mostly suggestive of a reduced arterial cardiometabolic risk. Changes in LNG-IUD use were not related to long-term metabolic changes.